Form 8-K - Current report:
SEC Accession No. 0001829126-24-006725
Filing Date
2024-10-09
Accepted
2024-10-09 16:15:19
Documents
14
Period of Report
2024-10-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K opgeninc_8k.htm   iXBRL 8-K 35203
2 EXHIBIT 10.1 opgeninc_ex10-1.htm EX-10.1 14994
  Complete submission text file 0001829126-24-006725.txt   227131

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE opgn-20241003.xsd EX-101.SCH 2991
4 XBRL LABEL FILE opgn-20241003_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE opgn-20241003_pre.xml EX-101.PRE 22343
16 EXTRACTED XBRL INSTANCE DOCUMENT opgeninc_8k_htm.xml XML 3650
Mailing Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850
Business Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 301-869-9683
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

EIN.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37367 | Film No.: 241362942
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)